The ailing California-based firm, which also counts Teva, Ahnu, Sanuk and Hoka One One its portfolio, said in a statement it was exploring ways of enhancing stockholder value which “may include a sale or other transaction,” but cautioned that there “can be no assurance that the strategic review process will result in a transaction.”
The Ugg brand represents 83 percent of Deckers’ revenues.
Among companies circling Deckers, activist hedge fund Marcato Capital Management LP in February purchased a 6 percent stake in the firm, and disclosed in a filing with the U.S. Securities and Exchange Commission that it intends to engage with the firm’s leadership on “various operational initiatives or broader strategic initiatives including, but not limited to, potential acquisitions or sales of/or involving [Deckers] or certain of [its] businesses or assets.”
As reported in Footwear News, analysts in recent months have been down on the underperforming company, which delivered a third-quarter sales and earnings miss. Revenues declined 4.5 percent year-on-year to $760 million, below analyst expectations for revenues of $789 million.
The company is due to release its fourth-quarter earnings on May 25.